Abstract
e17031Background: Ridaforolimus (Rida) is a mammalian target of rapamycin (mTOR) inhibitor that has activity in solid tumors. Paclitaxel and carboplatin (PC) have broad antineoplastic activity in m...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
